LMNL News and Press, Liminal Biosciences Inc From 11/15/21

Liminal BioSciences (NASDAQ:LMNL): Q3 Net loss from continuing operations, net of taxes was $9.7M Cash balance of $116.7M Press Release For further details see: Liminal BioSciences reports Q3 results

Liminal BioSciences Reports Third Quarter 2021 Financial Results Canada NewsWire Closing of the Sale of a Rare Pediatric Disease Priority Review Vou cher for gross proceeds of USD105M Closing of the Sale of the Remaining Plasma-Derived Therapeuti...

Liminal BioSciences Announces Closing of Sale of Remaining Plasma-Derived Therapeutics Business PR Newswire LAVAL, QC and CAMBRIDGE, England , Oct. 15, 2021 /PRNewswire/ - Liminal BioSciences Inc. (Nasdaq: LMNL) ("Liminal BioSciences" or the "Company"), ...

Liminal BioSciences Announces Closing of Sale of Priority Review Voucher PR Newswire LAVAL, QC and CAMBRIDGE, England , Sept. 28, 2021 /PRNewswire/ - Liminal BioSciences Inc. (NASDAQ: LMNL) ("Liminal BioSciences" or the "Company"), announced today that i...

Liminal BioSciences Inc. (LMNL) Q2 2021 Earnings Conference Call August 17, 2021 08:30 AM ET Company Participants Shrinal Inamdar - Investor Relations & Communications Manager Bruce Pritchard - Chief Executive Officer Patrick Sartore - President Murielle Lortie - Chief Financial Officer C...

The following slide deck was published by Liminal BioSciences Inc. in conjunction with their 2021 Q2 earnings call. For further details see: Liminal BioSciences Inc. 2021 Q2 - Results - Earnings Call Presentation

Liminal BioSciences Reports Second Quarter 2021 Financial Results Canada NewsWire Receipt of FDA Approval for Ryplazim ® (plasminogen, human-tvmh) Receipt of a Rare Pediatric Disease Priority Review Voucher Signature of Agreement to Divest Pl...

Gainers: LMNL +15.0%. SONO +10.6%. HUT +8.2%. EBON +4.5%. CAN +4.0%. Losers: JRJC -13.8%. WDC -6.1%. SDGR -5.6%. OGI -4.5%. ISEE -2.7%. For further details see: LMNL, SONO, JRJC and WDC among after hours movers

Gainers: Fulcrum Therapeutics (NASDAQ:FULC) +84%, Allied Healthcare Products (NASDAQ:AHPI) +39%, IMV (NASDAQ:IMV) +29%, Exagen (NASDAQ:XGN) +26%, Myomo (NYSE:MYO) +22%. Losers: SmileDirectClub (NASDAQ:SDC) -23%, EyeGate Pharmaceutica...

Liminal BioSciences (NASDAQ: LMNL) is one of the best-performing stocks on the public market today. If you want to invest in Liminal BioSciences, or if you simply want to find out more about the company and why it is surging in value, this article should answer all of your q...